Genes, Environment, Intermediate Phenotypes, and the Pathogenesis of Diabetic Nephropathy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|2|1|61-74

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.2, Iss.1, 2004-03, pp. : 61-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diabetic nephropathy

By Wylie Emma C   Satchell Simon C  

Clinical Medicine, Vol. 12, Iss. 5, 2012-10 ,pp. : 480-482

Royal College Of Physicians

Access to resources Recommend Favorite

Editorial [Hot Topic: Pathogenesis and Treatment of Diabetic Complications,Retinopathy, Nephropathy and Cardiomyopathy (Executive Editor: J.L. Wilkinson-Berka)]

By  

Current Pharmaceutical Design, Vol. 13, Iss. 26, 2007-09 ,pp. : 2698-2698

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor (VEGF) in the Pathogenesis of Diabetic Nephropathy of Type 1 Diabetes Mellitus

By  

Current Drug Targets, Vol. 12, Iss. 1, 2011-01 ,pp. : 107-114

Bentham Science Publishers

Access to resources Recommend Favorite

Aliskiren a winner in diabetic nephropathy

By  

Inpharma, Vol. 1, Iss. 1642, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Losartan: In Diabetic Nephropathy

By Carswell C.I.   Goa K.L.  

Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. : 407-414

Adis International

Access to resources Recommend Favorite